Question 1

What Causes Chronic Kidney Disease in Cats?

Accepted Answer

The causes of CKD in cats are multifactorial. Most cases are idiopathic, but several contributing factors are recognised:

Chronic interstitial nephritis (CIN) is the hallmark histopathologic finding, characterised by progressive fibrosis and tubular atrophy [33]. This process is partly linked to abnormal lipid metabolism, as feline renal proximal tubular cells naturally accumulate lipid droplets (triglycerides and ether-soluble triacylglycerols) that may drive inflammation [33].
Genetic predisposition: Approximately 20% of domestic cats harbour a duplication of exon 3 in the apoptosis inhibitor of macrophages (AIM) gene [20]. This variant produces a dysfunctional AIM protein that impairs clearance of intratubular debris, accelerating CKD progression.
Acute kidney injury (AKI) episodes: Events such as ureteral obstruction, pyelonephritis, or toxin exposure can initiate or worsen CKD. Inflammatory/ischemic causes are the most common triggers for AKI in cats [2].
Systemic hypertension: While often a consequence of CKD, hypertension also perpetuates renal damage. Circulating renin-angiotensin-aldosterone system (RAAS) markers are altered in hypertensive cats, though evidence of classic RAAS activation is not consistently found [15].
Comorbidities: Cardiovascular disease, hypersomatotropism (acromegaly), and pancreatitis frequently coexist with CKD and can influence progression [31, 39]. For example, cats with CKD often have elevated serum feline pancreatic lipase (fPL) due to reduced renal clearance, complicating pancreatitis diagnosis [24].
Congenital anomalies: Rarely, cats may be born with unilateral renal agenesis and contralateral ectopia, which predisposes them to early-onset CKD [4].

Question 2

What Are the Early Signs of Kidney Disease?

Accepted Answer

Early CKD is notoriously silent. Common signs emerge gradually and may be dismissed as normal aging:

Polyuria and polydipsia (PU/PD): Increased thirst and urination are the earliest symptoms. Smart litter box monitors can detect increased urination frequency, longer durations, and reduced covering behaviour, achieving 89.9% accuracy in predicting CKD [14].
Weight loss and muscle wasting: Reduced appetite and poor body condition are strong predictors of survival [19].
Lethargy: Anaemia of CKD, driven by decreased erythropoietin (EPO) production, contributes to fatigue [16]. Novel oral therapies such as molidustat (a HIF-PH inhibitor) can stimulate endogenous EPO and improve haematocrit [37].
Poor coat quality and halitosis: Uraemic toxins cause oral ulcers and ammonia-like breath.

"Red-flag signs" that warrant immediate veterinary attention include:

Vomiting, diarrhoea, or anorexia (often due to advanced uraemia)
Marked lethargy or weakness (suggesting severe anaemia or electrolyte disturbances)
Seizures or collapse (could indicate hypertensive encephalopathy or hypocalcaemia)
Acute onset of blindness (often due to hypertensive retinal detachment)
Straining to urinate or blood in urine (may indicate urinary tract infection or obstruction)

Ionized hypocalcemia is common but typically mild; severe hypocalcemia (iCa < 0.75 mmol/L) occurs in only 1.3% of azotemic cats and may cause muscle twitching or tetany [2].

Question 3

How Is CKD Diagnosed?

Accepted Answer

Diagnosis relies on a combination of history, physical examination, laboratory tests, and imaging:

Serum biochemistry: Creatinine > 140 µmol/L (1.6 mg/dL) indicates azotemia, but its sensitivity is limited by muscle mass and tubular secretion. Symmetric dimethylarginine (SDMA) is a more sensitive early marker (detects decline before creatinine rises) and is now recommended by the International Renal Interest Society (IRIS) [35].
Urinalysis: Urine specific gravity (USG) < 1.035 in a dehydrated cat suggests renal concentrating impairment. Proteinuria (urine protein:creatinine ratio > 0.4) is associated with poorer outcomes [30].
Imaging: Renal ultrasonography reveals decreased corticomedullary differentiation, small kidneys, or hydronephrosis. Advanced techniques such as computed tomography (CT) can quantitate renal parenchymal volume, which predicts post-operative creatinine after surgery for hydronephrosis [1]. Diffusion-weighted MRI may detect microstructural fibrosis non-invasively [3].
Emerging biomarkers: Urinary fibroblast growth factor-23 (uFGF23) and soluble alpha-Klotho (uKL) are increasingly used to assess mineral bone disorder and predict progression [30, 34]. Elevated uFGF23 and decreased uKL:creatinine ratio are linked to advanced CKD [30]. Serum amyloid A (SAA) is a reliable tool to differentiate pyelonephritis from stable CKD (threshold 49.1 mg/L, sensitivity 95%, specificity 97%) [13, 18].
Blood pressure: Systolic blood pressure measurement should be performed at every visit; hypertension (SBP > 160 mmHg) is both a cause and consequence of CKD [15].
Staging: The IRIS system stages CKD from 1 (non-azotemic with other abnormalities) to 4 (severe azotemia). Staging guides therapy and prognosis.

Question 4

What Are the Treatment Options?

Accepted Answer

Treatment focuses on slowing progression, managing complications, and maintaining quality of life. Key elements include:

1. Nutritional management
A therapeutic renal diet is the cornerstone. These diets are restricted in phosphorus, protein, and sodium but supplemented with omega-3 fatty acids, potassium, and B vitamins. A calcium:phosphorus ratio of approximately 1.4:1 is recommended; higher ratios do not significantly benefit calcium homeostasis and may raise ionized calcium [9]. Phosphate restriction lowers fibroblast growth factor-23 (FGF23) concentrations and reduces calciprotein particle formation, which are linked to soft tissue mineralisation [34]. The slope of reciprocal creatinine plots can objectively identify progressive vs. stable disease; a cutoff of −9.5 × 10⁻⁵ L/µmol/month distinguishes the two [28].

2. Management of anaemia
Recombinant human erythropoietin carries risks of pure red cell aplasia. The hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) molidustat is a safer oral alternative. In a randomised controlled trial, 68% of cats receiving 5 mg/kg molidustat achieved a ≥4% point increase in haematocrit within 28 days, compared to 17% in controls [37]. Roxadustat, another HIF-PHI with a longer half-life, shows promise in healthy cats but requires careful dosing (avoid >20 mg/kg due to toxicity) [6]. Taurine supplementation can also stimulate EPO production via the HIF-1α pathway [23]. Monitoring iron status is essential, as both absolute and functional iron deficiency impair response [16].

3. Control of hypertension and proteinuria
Amlodipine besylate (0.625-1.25 mg/cat once daily) is first-line for hypertension. ACE inhibitors (e.g., benazepril) reduce proteinuria but do not consistently slow progression. Amlodipine therapy increases angiotensin II and III concentrations, which may reflect beneficial RAAS modulation [15].

4. Electrolyte and acid-base balance
Hyperphosphataemia is managed with dietary restriction and phosphate binders (e.g., aluminium hydroxide). Hypokalaemia is common and can be corrected with potassium gluconate. Metabolic acidosis from impaired ammonia excretion requires alkalinisation (e.g., sodium bicarbonate). Note that the urine ammonia-to-creatinine ratio (UACR) is significantly lower in the fed state in CKD cats, so sampling conditions should be standardised [40].

5. Symptomatic and supportive care

Subcutaneous fluids (e.g., lactated Ringer's solution) administered at home can palliate dehydration and nausea. However, overzealous fluid therapy in cats with concurrent heart failure must be avoided [31].
Antiemetics (maropitant, ondansetron) and appetite stimulants (mirtazapine) improve food intake.
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) like bexagliflozin have been used successfully in a cat with advanced CKD and congestive heart failure as a decongestive strategy, but require vigilant monitoring for euglycemic ketoacidosis [27].

6. Surgical interventions
For benign ureteral obstruction, tailored ureteroneocystostomy with tension-relieving techniques yields a 12-month survival rate of 89.4% and lower complication rates than traditional implant-based bypasses [32]. Pre-operative CT measurement of contralateral renal parenchymal volume helps predict long-term creatinine [1].

7. Emerging therapies

Mesenchymal stem cells (MSCs): Clinical studies show consistent trends toward improved GFR and quality of life, though statistical significance is rarely achieved. Muse-like stem cells (a pluripotent subset of MSCs) have normalized renal markers in a 16-year old dog with CKD [22, 26].
Medicinal mushroom extracts: Ganoderma lucidum and Polyporus umbellatus suppress TGF-β1-induced epithelial-mesenchymal transition in feline renal cells, with additive antifibrotic effects when combined [29].
Cathepsin S inhibition: In mouse models, CatS deficiency prevents stress-related renal remodelling and hypertension, suggesting a potential therapeutic target [7].

Question 5

How Can I Care for My Cat with CKD at Home?

Accepted Answer

Home care is critical. The AVMA and Cornell Feline Health Center recommend:

Encourage water intake: Provide multiple water bowls, pet fountains, and wet food. Aim for a moist diet (canned food > 70% moisture).
Monitor weight and body condition weekly: Loss of body condition score (BCS) is an independent risk factor for mortality [19].
Ensure a stress-free environment: Chronic stress worsens CKD via inflammation and oxidative stress [7]. Hair cortisol concentrations have been studied as a marker of chronic stress, though a recent article on the topic has been retracted [21]. Nevertheless, providing hiding spots, perches, and consistent routines is advisable.
Administer medications consistently: Renal diets and phosphate binders are only effective if consumed.
Check for urinary tract infections: Subclinical bacteriuria (SBU) is common and does not require treatment unless signs of lower urinary tract disease develop; antibiotic treatment does not prevent persistence or progression [19].
Use safe sedatives when needed: For non-invasive procedures (e.g., ultrasound), a protocol of gabapentin, butorphanol, midazolam, and alfaxalone does not alter SDMA or creatinine, making it safe for CKD cats [10].
Monitor behaviour: A smart litter box can provide early warning of decompensation [14].

Question 6

What Is the Prognosis for Cats with CKD?

Accepted Answer

Prognosis varies widely. Stable cats (based on reciprocal creatinine slope) have a median survival of 894 days vs. 287 days for progressive cats [28]. Factors associated with faster progression include higher baseline FGF23, lower albumin, advancing age, and negative slope of reciprocal creatinine within the first 84 days [28]. Cats with IRIS stage ≥3 at one month post-operatively have significantly shorter survival [32]. The presence of comorbidities, especially anaemia and dental disease, independently reduces health-related quality of life scores [36].

Zubair Khalid

Chronic Kidney Disease in Cats

Quick Q&A

What Causes Chronic Kidney Disease in Cats?

What Are the Early Signs of Kidney Disease?

How Is CKD Diagnosed?

What Are the Treatment Options?

How Can I Care for My Cat with CKD at Home?

What Is the Prognosis for Cats with CKD?

Frequently Asked Questions

Can chronic kidney disease be reversed in cats?

How often should my cat with CKD see the veterinarian?

Is a renal diet necessary if my cat refuses to eat it?

Can I give my cat with CKD supplements like fish oil or probiotics?

What are the signs of end-stage kidney disease in cats?

References